Related items
Showing items related by title, author, creator and subject.
-
High levels of Hepatitis B surface antigen (HBsAg) can exclude significant fibrosis and distinguishes true 'immune-tolerance' in children and young adults with Chronic Hepatitis B
Hansi, NK; Gill, US; Banerjee, A; Surendraraj, N; Patel, C; Naik, S; Foster, GR; Kennedy, PT (2014) -
SEQUENTIAL ORAL ANTI-VIRAL THERAPY FOLLOWING PEGYLATED-INTERFERON-ALPHA FAILURE SIGNIFICANTLY INCREASES HBSAG DECLINE
Gill, US; Payaniandy, L; Schulz, J; Payaniandy, D; Ross, V; Kallis, Y; Kooner, P; Marley, R; Foster, GR; Kennedy, PT (2013-06) -
Genotype Specific Differences In Magnitude Of HBsAg Reduction During TDF or tenofovir alfenamide (TAF) Therapy In CHB Patients
Marcellin, P; Seto, W-K; Hu, C-T; Yurdaydin, C; Foster, GR; Flaherty, JF; Kim, K; Suri, V; Gaggar, A; Subramanian, M (2016-10)